Journal Article

Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI)

Francesco D'Agostini, Alberto Izzotti, Carlo Bennicelli, Anna Camoirano, Elena Tampa and Silvio De Flora

in Carcinogenesis

Volume 23, issue 4, pages 587-593
Published in print April 2002 | ISSN: 0143-3334
Published online April 2002 | e-ISSN: 1460-2180 | DOI:
Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI)

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


Several studies have shown that hexavalent chromium [Cr(VI)] induces apoptosis in a variety of in vitro test systems. We instilled intra-tracheally either saline or sodium dichromate (0.25 mg/kg body weight), for three consecutive days, to Sprague–Dawley rats. TUNEL analyses showed a marked increase of the apoptotic index in both bronchial epithelium and lung parenchyma of Cr(VI)-treated rats, but no effect was detected in their liver. In parallel, the expression of 13 out of 18 apoptosis-related genes, evaluated by cDNA array analysis, was significantly enhanced in rat lung. The overexpressed genes included c-Jun N-terminal kinases 1, 2 and 3, bcl-x, bcl-2-associated death promoter and bcl-2-related ovarian killer protein, caspases 1, 3 and 6, DNase I precursor, DNA topoisomerases I and II alpha, and poly(ADP-ribose) polymerase. The enhancement of p53 expression in the lung was borderline to statistical significance. Expressions of bcl-2, bax-alpha, mdm2 and DNA topoisomerase IIB were not enhanced to a significant extent in lung. No induction of gene expression was observed in rat liver. RT-PCR analyses confirmed that Cr(VI) enhances the expression of c-Jun N-terminal kinase 1, caspase 6, and DNase I precursor but not that of bcl-2 in lung, while none of these genes was overexpressed in the liver of Cr(VI)-treated rats. The lack of stimulation of apoptosis in the liver parallels the failure of Cr(VI) to produce genotoxic damage, as we previously observed under identical experimental conditions. These negative findings may be ascribed to reduction of Cr(VI) to Cr(III) when traveling from the respiratory tract to the liver. On the other hand, induction of apoptosis in the respiratory tract parallels the occurrence of genotoxic effects and oxidative DNA damage produced by Cr(VI) in the same tissue. As previously shown in another laboratory, Cr(VI) did not induce lung tumors after 30 months of administration of the same daily dose. Therefore, apoptosis is likely to provide a protective mechanism at a post-genotoxic stage of Cr(VI) carcinogenesis.

Keywords: Cr(VI)/Cr(V)/Cr(IV)/Cr(III), hexavalent/pentavalent/tetravalent/trivalent chromium; TUNEL, TdT-mediated dUTP nick end labeling; JNK, c-Jun N-terminal kinase; BAD, bcl-2-associated death promoter; BOK, bcl-2-related ovarian killer protein; DNase, deoxyribonuclease; mdm2, murine double minute-2; PARP, poly(ADP-ribose) polymerase; ELF, epithelial lining fluid; PAM, pulmonary alveolar macrophages; ROS, reactive oxygen species; RT-PCR, reverse transcription-polymerase chain reaction.

Journal Article.  4998 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.